Evidence map›Paper›PMID 22464285›Full record

ArticleAtherosclerosis2012

ω-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination.

Jia Fei, Carla Cook, Nalini Santanam

Abstract read
In one paragraph

Article in Atherosclerosis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Frontiers in pharmacology · 2024
    Article
  3. Activating the PGC-1Oxidative medicine and cellular longevity · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jia FeiDepartment of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
Carla Cook
Nalini Santanam
Marshall University · US

Funding

WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
Oxidized Lipids in Cardiovascular DiseaseR01HL074239 · NHLBI · MARSHALL UNIVERSITY · PI SANTANAM, NALINI · 2004 to 2008
$1.8M
NCRR NIH HHS 5P20RR016477NCRR NIH HHS P20 RR016477NHLBI NIH HHS 5R01HL-074239NHLBI NIH HHS R01 HL074239
6 · The paper itself

Abstract

objectiveDietary ω-6 lipids such as linoleic acid and its oxidized forms (13-HPODE OxLA) interact with peroxisome proliferator-activated receptors (PPARs) and elicit pro and anti-atherogenic effects in vascular cells. Ligand-dependent PPAR protein turnover is promoted by ubiquitination, but attenuated by binding to its co-activator, peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1α). The objective of our study was to investigate if the dual atherogenic effects of ω-6 lipids are due to its regulation of PPAR turnover. METHODS AND

resultsIn rat aortic smooth muscle cells (RASMCs), oxidized linoleic acid (OxLA) at 10-50 μM induced and stabilized PPARα protein at earlier time points (0-4 h) but suppressed it at 12 h. Conversely, it activated PPARγ protein turnover at a later time point (12 h). Pre-treatment with the proteasome inhibitor (MG132) prevented OxLA mediated loss of PPAR stability and transactivity. Co-immunoprecipitation studies indicated a ligand mediated time-dependent reciprocal exchange of PPAR interaction between ubiquitination and PGC-1α. This ω-6 lipid mediated time-dependent switch between PPAR degradation versus stability helped modulate the pro and anti-atherogenic effects of these dietary lipids.

conclusionOur findings provide insights into the dual pro and anti-atherogenic effects of dietary ω-6 lipids on vascular cells by the regulation of PPAR turnover.

Indexed as

AnimalsAortaCells, CulturedCysteine Proteinase InhibitorsGene Expression RegulationImmunoprecipitationLeupeptinsLigandsLinoleic AcidMuscle, Smooth, VascularMyocytes, Smooth MuscleOxidation-ReductionPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR alphaPPAR gammaProteasome Endopeptidase Complexbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCysteine Proteinase InhibitorsLeupeptinsLigandsLinoleic AcidPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR alphaPPAR gammaPpargc1a protein, ratProteasome Endopeptidase ComplexProteasome InhibitorsRNA-Binding ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID22464285
PMCPMC3361620
OpenAlexW1969979809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.